Correlation Between Alar Pharmaceuticals and Apex Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alar Pharmaceuticals and Apex Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alar Pharmaceuticals and Apex Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alar Pharmaceuticals and Apex Biotechnology Corp, you can compare the effects of market volatilities on Alar Pharmaceuticals and Apex Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alar Pharmaceuticals with a short position of Apex Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alar Pharmaceuticals and Apex Biotechnology.

Diversification Opportunities for Alar Pharmaceuticals and Apex Biotechnology

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Alar and Apex is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Alar Pharmaceuticals and Apex Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apex Biotechnology Corp and Alar Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alar Pharmaceuticals are associated (or correlated) with Apex Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apex Biotechnology Corp has no effect on the direction of Alar Pharmaceuticals i.e., Alar Pharmaceuticals and Apex Biotechnology go up and down completely randomly.

Pair Corralation between Alar Pharmaceuticals and Apex Biotechnology

Assuming the 90 days trading horizon Alar Pharmaceuticals is expected to generate 3.06 times more return on investment than Apex Biotechnology. However, Alar Pharmaceuticals is 3.06 times more volatile than Apex Biotechnology Corp. It trades about 0.37 of its potential returns per unit of risk. Apex Biotechnology Corp is currently generating about 0.16 per unit of risk. If you would invest  12,500  in Alar Pharmaceuticals on November 19, 2024 and sell it today you would earn a total of  2,700  from holding Alar Pharmaceuticals or generate 21.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Alar Pharmaceuticals  vs.  Apex Biotechnology Corp

 Performance 
       Timeline  
Alar Pharmaceuticals 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Alar Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Alar Pharmaceuticals is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Apex Biotechnology Corp 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Apex Biotechnology Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Apex Biotechnology may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Alar Pharmaceuticals and Apex Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alar Pharmaceuticals and Apex Biotechnology

The main advantage of trading using opposite Alar Pharmaceuticals and Apex Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alar Pharmaceuticals position performs unexpectedly, Apex Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apex Biotechnology will offset losses from the drop in Apex Biotechnology's long position.
The idea behind Alar Pharmaceuticals and Apex Biotechnology Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bonds Directory
Find actively traded corporate debentures issued by US companies